A review of current evidence for vilazodone in major depressive disorder

Cost-Effectiveness of Adjunctive Therapy with Atypical Antipsychotics for Acute Treatment of Major Depressive Disorder

(2012) Charu Taneja et al.   ANNALS OF PHARMACOTHERAPY

Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

(2012) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

(2011) Arif Khan et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Association between Economic Status and Depressive Symptoms: An Individual and Community Level Approach

(2011) Sun-Jin Jo et al.   Psychiatry Investigation

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

(2009) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study

(2009) Pierre Blier et al.   AMERICAN JOURNAL OF PSYCHIATRY

Vilazodone: A 5-HT1AReceptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders

(2009) Lee A. Dawson et al.   CNS Neuroscience & Therapeutics

Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression

(2009) Arif Khan   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination

(2009) James H. Kocsis et al.   JOURNAL OF CLINICAL PSYCHIATRY

Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder

(2009) Karl Rickels et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation

(2009) B S McEwen et al.   MOLECULAR PSYCHIATRY

Low-Dose Buspirone, Melatonin and Low-Dose Bupropion Added to Mood Stabilizers for Severe Treatment-Resistant Bipolar Depression

(2009) Andrew A. Nierenberg   PSYCHOTHERAPY AND PSYCHOSOMATICS

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

(2008) IM Anderson et al.   JOURNAL OF PSYCHOPHARMACOLOGY